Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Pediatr Hematol Oncol 23 , 381385
Tirzepatide (Mounjaro's active ingredient) stimulates both GLP-1 and GIP receptors, while semaglutide (Ozempic's active ingredient) primarily targets GLP-1 receptors
Last Updated on April 27, 2026 Youve probably heard some version of this phenomenon by now: people take Ozempic (or another GLP-1) and suddenly lose interest in alcohol
Explore the data, category trends, and practical strategies growers, shippers, marketers, retailers, and more can use to better connect with the GLP1 consumer and capture longterm growth opportunities
Pros Online medical intake and clinician review
US$ 28.76
US$ 20.39
US$ 27.56
US$ 27.85
